A Phase II Safety and Tolerability Study With SEN0014196

Clinical trial NCT01521585 · COMPLETED

Trial details

NCT number: NCT01521585
Sponsor: Siena Biotech S.p.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Huntington's Disease

Start date: 2011-11-01
Primary completion: 2012-10-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.